Olon S.p.A. announced the start of the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.
"I am pleased to announce the start of this GMP capacity expansion just within 6 months after the acquisition of Capua BioServices. This truly confirms the real opportunity to accelerate growth in Olon's CDMO service positioning and to be recognized as European Leader in the CDMO of microbial fermentation," Paolo Tubertini, CEO of Olon, said.
The construction of this new GMP facility is associated to a long-term strategic partnership with a large pharmaceutical company. The engineering project is designed to support the manufacture of multiple products, up to commercial scale.